Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Defensin beta 108F (DEFB108F, also known as DEFB108P5 or beta-defensin 108B-like) is a gene locus annotated as a pseudogene in the human genome. Pseudogenes such as DEFB108F are non-functional segments of DNA that closely resemble genes encoding beta-defensins, a family of small, cysteine-rich antimicrobial peptides involved in innate immunity. Functional beta-defensins are known to disrupt microbial membranes and contribute to defense against infection, but DEFB108F shows no evidence of protein expression or biological activity and is not considered a protein-coding therapeutic target, disease biomarker, or direct druggable entity. Beta-defensins as a class are well-studied for roles in antimicrobial defense. DEFB108F is part of a rapidly evolving, duplicated multigene family; many human DEFB genes are pseudogenes. No protein structure, peptide data, or functional assays for DEFB108F exist in the literature, distinguishing it from functionally-validated beta-defensins like beta-defensin 2 (DEFB4A) or hBD-2. DEFB108F is a defensin beta pseudogene without established functional protein product, biological role, or druggability. It is an example of the genomic complexity and rapid evolution of the beta-defensin gene family, with many human defensins being non-functional duplicates or pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Defensin beta 108 pseudogene 5 (DEFB108F).